Results 171 to 180 of about 10,422 (209)

Impact of GABA and nutritional supplements on neurochemical biomarkers in autism: a PPA rodent model study. [PDF]

open access: yesFront Mol Neurosci
Alabdali AN   +6 more
europepmc   +1 more source

CNS pharmacology of NKCC1 inhibitors

open access: yesNeuropharmacology, 2022
The Na-K-2Cl cotransporter NKCC1 and the neuron-specific K-Cl cotransporter KCC2 are considered attractive CNS drug targets because altered neuronal chloride regulation and consequent effects on GABAergic signaling have been implicated in numerous CNS disorders.
Wolfgang Löscher, Kai Kaila
exaly   +5 more sources

Pharmacological tools to target NKCC1 in brain disorders [PDF]

open access: yesTrends in Pharmacological Sciences, 2021
The chloride importer NKCC1 and the chloride exporter KCC2 are key regulators of neuronal chloride concentration. A defective NKCC1/KCC2 expression ratio is associated with several brain disorders. Preclinical/clinical studies have shown that NKCC1 inhibition by the United States FDA-approved diuretic bumetanide is a potential therapeutic strategy in ...
Annalisa Savardi   +2 more
exaly   +3 more sources

Increased NKCC1 expression in refractory human epilepsy

open access: yesEpilepsy Research, 2007
Cation-chloride co-transporters (CCTs), particularly NKCC1, may be important in epileptogenesis. We have performed a detailed histological examination of NKCC1 in large samples of patients with hippocampal sclerosis (HS) or focal cortical dysplasia (FCD), pathologies both commonly associated with pharmacoresistant epilepsy.
Arjune Sen   +2 more
exaly   +3 more sources

Home - About - Disclaimer - Privacy